Trials / Completed
CompletedNCT04066842
Vitamin D in Systemic Sclerosis Patients With Periodontitis
Evaluation Of Vitamin D In Systemic Sclerosis Patients With Periodontitis: A Possible Role In Cardiovascular Disease Risk Progression?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 168 (actual)
- Sponsor
- University of Messina · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Vitamin D has been considered to possess anti-inflammatory and antimicrobial activity which may be a link for the known interaction of Systemic Sclerosis (SSc) and coronary heart disease (CHD). This study investigated the association between serum vitamin D levels and SSc and periodontitis in patients with SSc, CP and with CHD. Furthermore, the objective was to determine if periodontitis and CHD had an impact on serum vitamin D levels.
Detailed description
Using a cross-sectional design, a total of 42 patients with SSc, 43 patients with CHD, 41 patients with both SSc and CP, and 42 healthy patients were enrolled in the present study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observation | Evaluation of Vitamin D levels and correlation of Vitamin D levels level with periodontal and cardiovascular disease |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2019-05-15
- Completion
- 2019-05-30
- First posted
- 2019-08-26
- Last updated
- 2019-08-26
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04066842. Inclusion in this directory is not an endorsement.